贫血与输血对冠状动脉旁路移植术后长期生存的叠加效应
该回顾性分析纳入2000至2015年葡萄牙一家学术医院连续5243例首次孤立冠状动脉旁路移植术患者,比较贫血与红细胞输血对10年全因死亡的独立与联合效应。术前贫血占31%,27.0%接受至少一次浓缩红细胞输注;贫血且输血者10年死亡风险最高(HR 2.25)。
要点
- 术前贫血占31%,27.0%患者接受至少一次浓缩红细胞输注。
- 贫血且输血者10年全因死亡风险最高,HR 2.25(95%CI 1.97–2.56,P<0.001)。
- 仅输血者10年死亡风险未达统计学显著(HR 1.14,95%CI 1.00–1.31,P=0.053)。
核心结论
- 这项纵向人群水平研究强调术前贫血与围术期红细胞输血对长期结局的不良影响。
- 研究强调对输血高风险患者采取循证、多模式、多学科血液资源保护策略以优化结局的重要性。
研究设计与样本
- 回顾性分析2000至2015年葡萄牙一家学术医院连续5243例首次孤立冠状动脉旁路移植术患者。
- 术前贫血患者1649例(A+),围术期接受输血患者1422例(T+),组成A-/T-、A-/T+、A+/T-、A+/T+四个亚组。
- 主要终点为10年全因死亡,采用逆概率加权控制混杂变量。
主要发现
- 31%患者有术前贫血,27.0%患者接受至少一次浓缩红细胞输注。
- 逆概率加权有效消除了所有显著基线特征的差异。
- 10年全因死亡在A-/T-组568例(20.5%),A-/T+组204例(24.4%)(HR 1.14,95%CI 1.00–1.31,P=0.053)。
- 10年全因死亡在A+/T-组358例(33.8%)(HR 1.53,95%CI 1.38–1.71,P<0.001)。
- 10年全因死亡在A+/T+组254例(43.6%)(HR 2.25,95%CI 1.97–2.56,P<0.001)。
关键数值与推荐
- 术前贫血定义为A+组1649例,围术期输血定义为T+组1422例。
- 10年全因死亡A-/T-组20.5%(568例)vs A-/T+组24.4%(204例),HR 1.14(95%CI 1.00–1.31,P=0.053)。
- 10年全因死亡A-/T-组20.5%(568例)vs A+/T-组33.8%(358例),HR 1.53(95%CI 1.38–1.71,P<0.001)。
- 10年全因死亡A-/T-组20.5%(568例)vs A+/T+组43.6%(254例),HR 2.25(95%CI 1.97–2.56,P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the independent and combined effects of anaemia and red blood cell transfusion on late survival after isolated coronary artery bypass grafting. METHODS: Retrospective analysis of 5243 consecutive patients undergoing primary isolated coronary artery bypass grafting, performed from 2000 to 2015, in a Portuguese Academic Hospital. We identified 1649 patients with preoperative anaemia (A+) and 1422 patients who received a perioperative transfusion (T+)-the 4 possible combinations allowed for the creation of 4 subgroups (A-/T-, A-/T+, A+/T- and A+/T+). The primary endpoint was all-cause mortality at 10 years. We employed inverse probability weighting to control for confounding variables. RESULTS: Thirty-one percent of the patients had preoperative anaemia, and 27.0% had at least one packed red blood cell transfusion. Inverse probability weighting was effective in eliminating differences in all significant baseline characteristics. The primary endpoint of all-cause mortality at 10 years occurred in 568 patients (20.5%) in the A-/T- group, as compared with 204 (24.4%) in the A-/T+ group (hazard ratio, 1.14; 95% confidence interval, 1.00 to 1.31; P = 0.053), 358 (33.8%) in the A+/T- group (hazard ratio, 1.53; 95% confidence interval, 1.38 to 1.71; P < 0.001), 254 (43.6%) in the A+/T+ group (hazard ratio, 2.25; 95% confidence interval, 1.97 to 2.56; P < 0.001). CONCLUSIONS: This longitudinal, population-level study emphasizes the adverse long-term outcomes of preoperative anaemia and perioperative red blood cell transfusion. It stresses the importance of an evidence-based, multimodal and multidisciplinary approach to conserving blood resources and optimizing outcomes in patients at high risk for transfusion.
引用
- Abreu A, Máximo J, Almeida C, et al. The additive effects of anaemia and transfusion on long-term survival after coronary artery bypass surgery. Eur J Cardiothorac Surg. 2024. PMID: 38058180. doi:10.1093/ejcts/ezad403
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。